Key macro instruments that drive energy prices: dollar, crude benchmarks, gas markets, energy stocks
Bernstein Hikes Delta Air Lines Price Target to $88 on Better Fuel Insulation
Bernstein raised its price target on Delta Air Lines (NYSE:DAL) to $88 from $81, reiterating an Outperform rating on the carrier. The firm’s thesis centers on Delta’s superior “fuel insulation,” a structural edge that matters more as oil prices remain elevated.
22m ago
Stock Market Today: Dow Wavers, Oil Rises After Trump Rejects Peace Deal; Micron, Nvidia Jump (Live Coverage)
Stock Market Today: The major indexes edged lower Monday while oil prices rose on Iran tensions. Intel, Lumentum, Moderna, Micron are winners.
27m ago
Oil jumps 4% as Trump rejects Iran’s response to ceasefire proposal
Oil prices jumped on Monday morning while European markets edged lower and Asian stocks rose to new all time highs after US President Donald Trump rejected Tehran’s response to the latest proposal on ending the war in Iran.
37m ago
JPMorgan issues stark warning on gas prices and inflation
The U.S.-Iran conflict, now in its third month, has torn through global oil supply at a historic pace. Yet prices at the pump, while painful, haven't spiked as violently as past crises might suggest.
38m ago
Why Bernie Sanders Is Wrong About Gas Prices
When lawmakers propose solutions to complex economic problems, the first requirement should be a clear understanding of how those problems actually work. A recent Facebook post by Bernie Sanders comparing today’s oil and gasoline prices to those in 2011 suggests that oil companies are “ripping off” consumers. The logic is straightforward: if oil prices are roughly the same, gasoline prices should be as well. If they aren’t, someone must be taking advantage.
45m ago
Oil Prices Surge as Trump Slams Iran Over Peace Plan. Hormuz Reopening in Doubt.
U.S. oil prices jumped early Monday, nearing the $100-a-barrel mark, after President Donald Trump said Iran’s response to the U.S. proposal to end the war was “totally unacceptable.” Brent crude futures the international benchmark, rose 2.6% to $103.89 a barrel, while West Texas Intermediate futures were up 2.3% at $97.64. Iran said it would gradually reopen the Strait of Hormuz as the U.S. lifts its blockade of Iranian ships and ports, The Wall Street Journal reported, citing officials.
1h ago
Collins Aerospace, an RTX (NYSE: RTX) business, is investing $26.5 million to expand its Largo, Florida facility. This expansion will create over 100 new high-tech jobs in engineering and factory operations. The facility will accelerate production of commercial aviation radars and multi-domain security solutions for defense customers. The new radar production area is expected to become fully operational by late 2026. RTX employs more than 7,000 people across eight major locations in Florida and had 2025 sales of more than $88 billion.
Intercede Group plc announced that its CEO, Klaas van der Leest, and CFO, Nitil Patel, have each made binding commitments to subscribe for £1,800 of Partnership Shares from the April 2026 payroll at the prevailing market price. Matching Shares will be awarded on a one-for-one basis for each Partnership Share. Following the completion of these transactions, Klaas van der Leest's revised shareholding will be 2,322,683 ordinary shares (3.9% of issued share capital), and Nitil Patel's will be 60,097 ordinary shares (0.1% of issued share capital). The transactions were conducted at a price of 121.75p per share for a volume of 2,956 shares each on 7 May 2026. This matters to investors as it reflects executive participation in the company's share incentive scheme and updates on director shareholdings.
Open Text™ Corporation announced the completion of its divestiture of Vertica to Rocket Software Inc., a Bain Capital portfolio company, for US$150 million in cash before taxes, fees, and other adjustments. The transaction aligns with OpenText's non-core divestiture strategy and disciplined approach to capital allocation. OpenText intends to use the net proceeds from the divestiture to reduce outstanding debt. The agreement includes the transfer of software, client contracts, associated services, and employees to Rocket Software. This move allows OpenText to concentrate investment in its core businesses.
Lifeward Ltd. (Nasdaq: LFWD), a diversified biomedical innovation company, announced it will report its first quarter 2026 financial results before the U.S. markets open on Friday, May 15, 2026. Following the release, President and Chief Executive Officer Mark Grant and Chief Financial Officer Almog Adar will host a conference call and live webcast at 8:30 a.m. EDT to discuss the results. Lifeward operates in the United States, Israel, and Germany, and its portfolio includes neurorehabilitation technologies and a biomedical pipeline. The company is expanding into high-value therapeutic platforms, including its Protein Oral Delivery (POD™) platform with lead candidate ORMD-0801 (oral insulin).
MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company, announced that its late-breaking abstract on DA-1726, a novel dual oxyntomodulin (OXM) analog targeting GLP-1 and glucagon receptors for obesity treatment, has been accepted for poster presentation at the European Association for the Study of the Liver (EASL) Congress 2026 in Barcelona, Spain. DA-1726 is currently being evaluated in a 16-week Phase 1 Part 3 titration study, with data expected in the fourth quarter of this year. In pre-clinical and Phase 1 studies, DA-1726 demonstrated improved weight loss and metabolic effects compared to leading GLP-1 receptor agonists. MetaVia is also developing vanoglipel (DA-1241) for Metabolic Dysfunction-Associated Steatohepatitis (MASH). The company highlighted the differentiated profile and ongoing clinical progress of its pipeline.
Verizon Communications Inc. announced the commencement of offers to exchange any and all outstanding series of certain debt securities for newly issued notes of Verizon. The Exchange Offers are being made on behalf of certain wholly-owned subsidiaries and are subject to the terms and conditions set forth in the Exchange Offer and Consent Solicitation Statement dated May 11, 2026. Concurrently, Verizon is soliciting consents to proposed amendments to the indentures governing the old notes, aiming to eliminate certain restrictive covenants. Eligible Holders who tender old notes will be deemed to deliver their consent to the proposed amendments. The completion of any Exchange Offer is not conditioned on the receipt of the requisite consents in the related Consent Solicitation.
Eco Wave Power Global AB (publ) (NASDAQ: WAVE), a leading onshore wave energy technology company, announced its participation in the Centurion One Capital Inaugural Miami Summit on May 28, 2026, at the Faena Forum in Miami Beach, Florida. Inna Braverman, Founder and Chief Executive Officer, will present updates on the company's operational and commercial progress, including its grid-connected wave energy power station in Israel and a pilot project at the Port of Los Angeles. The company is expanding internationally with planned projects in Taiwan, India, and Portugal, representing a project pipeline of 404.7 MW. The announcement highlights Eco Wave Power's role in supporting renewable energy for AI-related facilities and energy-intensive coastal assets.
Boost Run, Inc. (Nasdaq: BRUN), an NVIDIA Preferred Cloud Partner, announced an operational and financial update highlighting its commercial momentum and expanding deployment capacity. The company enters its Nasdaq listing with $940M in long-term contracted revenue, with the majority already in production and the remainder scheduled for execution in FY2026. Boost Run expects to exit FY2026 with at least $375M in annualized recurring revenue and operates six U.S. data center locations, with five more in progress, expanding total accessible infrastructure capacity to over 125MW. The company maintains a track record of free cash flow generation and expects to remain FCF positive through ongoing deployments and expansion. These developments reflect Boost Run's continued growth and diversification across customers and sectors.
Standard Lithium Ltd. (TSXV: SLI) announced its financial and operating results for the three-month period ended March 31, 2026. The company signed its first binding commercial offtake agreement with Trafigura, covering over 40% of total targeted offtake commitments for the SWA Project. Major operational milestones were achieved at the Arkansas Demonstration Plant, including processing 1 million barrels of Smackover brine and completing over 15,000 DLE cycles over six years. As of March 31, 2026, the company reported cash and working capital of $141.0 million and $139.5 million, respectively, with no term or revolving debt obligations. Standard Lithium remains on track for a Final Investment Decision and beginning construction at the SWA Project in 2026.
CalEthos, Inc. (OTCQB:GEDC) and its subsidiary TerraVolt Infrastructure, Inc. announced the execution of an agreement with a top-tier natural gas marketing company for the FIRM supply of 55,000 MMBTU per day of natural gas for TerraVolt's planned behind-the-meter onsite power plant. This supply will support the initial phase of a master-planned data center campus development in Southeast Idaho, planned for 200MW to 240MW of power for data center customers. The agreement includes comprehensive fuel management services and aims to provide a stable, reliable energy source without impacting the local grid or increasing costs to local rate payers. The project aligns with President Trump’s March 4, 2026 Ratepayer Protection Pledge, requiring technology companies to pay for their own power infrastructure.
Valion Bio, Inc. (formerly Tivic Health Systems, Inc.) (Nasdaq: VBIO), a clinical-stage immunotherapeutics company, announced it will report financial results for the first quarter ended March 31, 2026, after market close on Thursday, May 14, 2026. The company is developing Entolimod™ for Acute Radiation Syndrome (ARS) and oncology supportive care, and Entolasta™ for broader therapeutic applications. Entolimod™ for ARS has received Fast Track and Orphan Drug designations from the U.S. Food and Drug Administration. Valion Bio's subsidiary, Velocity Bioworks, offers biomanufacturing services and supports the company's drug pipeline. The announcement includes details for a conference call and webcast to discuss financial results and provide a business update.
Cellectar Biosciences, Inc. (NASDAQ: CLRB) announced it will report financial results for the first quarter ended March 31, 2026, and provide a corporate update on May 14, 2026, at 8:30 a.m. Eastern Time. The company is a late-stage clinical biopharmaceutical company focused on developing proprietary drugs for cancer treatment. Its product pipeline includes iopofosine I 131, which has received multiple FDA and EMA designations, and other programs such as CLR 121125 (CLR 125) and CLR 121225 (CLR 225). The announcement provides details on the upcoming conference call and webcast for investors.
Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF) announced that its THERMAL-XR graphene coating solution is being applied to air conditioners for two luxury towers under construction at the Gold Coast in Queensland, Australia. The project involves spraying THERMAL-XR on between 300 to 600 air conditioners. The coating aims to provide energy savings, anti-corrosion benefits, and extended asset life for apartment owners and tenants. This application is highlighted as a significant milestone for GMG's commercial momentum in the Australian market. The company is also focused on developing energy storage solutions and scaling up its proprietary graphene production process.
Par Pacific Holdings, Inc. announced that its wholly owned subsidiary, Par Petroleum, LLC, intends to offer $500 million in aggregate principal amount of senior unsecured notes due 2034 in a private placement. The Notes are expected to be fully and unconditionally guaranteed on a senior unsecured basis by Par Pacific and certain subsidiaries. The company plans to use the net proceeds, along with cash on hand or borrowings under its ABL Credit Facility, to repay and terminate Par Petroleum’s term loan due 2030. Par Pacific owns and operates 219,000 bpd of refining capacity across four locations and an energy infrastructure network including 13 million barrels of storage. The offering is subject to market conditions and is not registered under the Securities Act.
Beyond Minerals Inc. (CSE: BY) (OTCQB: BYDMF) has completed a non-brokered private placement of 4,040,000 units at a price of $0.05 per unit, raising aggregate gross proceeds of $202,000. Each unit consists of one common share and one-half of one common share purchase warrant, with each whole warrant exercisable at $0.10 per share for 24 months. The company paid a cash commission of $11,620 and issued 232,400 broker warrants to an eligible third party. The net proceeds will be used for general working capital, exploration activities, expenditures on its Rare One project, marketing, and advertising. The offering was conducted under the LIFE Exemption in all provinces of Canada except Quebec.
Envoy Medical Inc. (NASDAQ: COCH) reported its first quarter 2026 results, highlighting the completion of enrollment in its pivotal U.S. clinical trial for the fully implanted Acclaim cochlear implant and the closing of an upsized public offering for up to $78.0 million. The company implanted the 56th and final patient on March 11, 2026, and is now collecting 12-month follow-up data, with a PMA submission to the FDA planned. Envoy Medical expanded its global IP portfolio to 47 patents and presented promising interim clinical data showing improved word recognition and no serious adverse events. As of March 31, 2026, the company reported net revenue of $39 and cash of approximately $25,251.
North America Home Finance Inc. (CSE: NAHF) announced the successful completion of its previously announced exchange offering, resulting in the issuance of 31,127 Series 1 Non-Voting Preferred Shares ('Housing Shares') in exchange for rights and bonds with an aggregate value of $322,231.15. The Housing Shares are now listed on the Canadian Securities Exchange under the symbol 'NAHF.PR.A', with trading expected to commence on May 12, 2026. This milestone is part of the company's strategy to provide home-equity-building opportunities and expand home ownership in North America. The Housing Shares are designed to align investors with the long-term performance of residential housing assets within NAHF's platform.
Aurania Resources Ltd. (TSXV: ARU) (OTCQB: AUIAF) announced its intention to complete a non-brokered private placement financing of up to 8,333,333 units at a price of C$0.18 per unit for aggregate gross proceeds of up to approximately C$1,500,000. The company has reserved the right to increase the size of the offering by up to 25%, potentially issuing an additional 2,083,333 units to raise up to approximately C$375,000 more. Each unit consists of one common share and one warrant, with each warrant exercisable at C$0.35 for 24 months. Net proceeds will primarily fund exploration at the Thor's Valley epithermal gold project in Iceland, the Balangero nickel-cobalt tailings retreatment project in Italy, and for general working capital. Certain directors and officers are expected to participate, and closing is anticipated on or about June 1, 2026, subject to regulatory approvals.
Deep Sea Minerals Corp. (CSE: SEAS, OTCQB: DSEAF) recapped its participation at the 2026 Offshore Technology Conference (OTC), held May 4 – 7, 2026, at the NRG Center in Houston, Texas. The company was represented by its CEO James Deckelman and VP of Exploration Dan McConnell, who also serves as Chair of the OTC Board of Directors. The conference highlighted the growing importance of marine minerals in the offshore industry and provided Deep Sea Minerals with opportunities to engage with regulators, service providers, and other stakeholders. The company remains focused on advancing critical mineral opportunities from the deep ocean and has commenced early-stage engagement with selected governments and regulatory bodies in the Pacific Ocean region.
3D Systems (NYSE: DDD) announced that ROE Dental Laboratory has purchased additional NextDent® 300 3D printers, tripling its manufacturing capacity for high-precision, multi-material monolithic dentures. This expansion highlights rapid commercial adoption of 3D Systems’ industry-first multi-material Jetted Denture Solution and reinforces its leadership in digital dentistry. ROE becomes the leading dental laboratory in the U.S. to scale at this pace with the NextDent Jetted Denture Solution, dramatically increasing throughput and validating the platform for digital denture production. The combined addressable market now exceeds 60 million edentulous patients, representing a multi-billion-dollar opportunity. The announcement also notes that U.S. and EU regulatory approvals are now in place.
Ceva, Inc. (NASDAQ: CEVA) announced a major customer win for its Bluetooth High Data Throughput (HDT) solution, including its internally developed RF technology. This marks a significant commercial milestone and validates Ceva's strategy to expand its wireless offering and deliver comprehensive, system-level solutions. The customer, a leading U.S.-based semiconductor company, has adopted Ceva's Bluetooth HDT platform, reflecting the company's evolution from component IP to full-stack wireless partner. Bluetooth 6.0 designs are entering production at multiple customers, with royalties beginning to ramp, and the Bluetooth connectivity market sees annual device shipments in the billions. Ceva's solutions are trusted by more than 400 customers worldwide, with over 21 billion devices shipped.
California Nanotechnologies Corp. (TSXV: CNO) announced its participation in the 16th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel in Los Angeles, CA on May 18th and 19th, 2026. The company is scheduled to present on Tuesday, May 19, 2026 at 4:00 PM PDT, with CEO Eric Eyerman presenting on behalf of the company. Cal Nano highlights its expertise in processing metallurgic powders into parts and its customer base ranging from Fortune 500 companies to startups. The company operates two manufacturing facilities for materials research and production needs. This announcement provides investors with information about the company's upcoming presentation and its capabilities.
Blue Sky Uranium Corp. (TSXV: BSK, OTCQB: BKUCF) announced that its joint venture company Ivana Minerales S.A. has executed service agreements with M3 Engineering & Technology and the Saskatchewan Research Council to support engineering and metallurgical testing for the Ivana Uranium-Vanadium Project in Rio Negro Province, Argentina. The agreements are intended to advance the project toward Pre-Feasibility and Feasibility level studies. The initial metallurgical testing program will involve approximately 900 kilograms of mineralized material. Abatare Spain, S.L.U. will fund cumulative expenditures of US$35 million to acquire a 49.9% indirect equity interest in the Ivana deposit, with the right to earn up to an 80% equity interest by funding up to US$160,000,000. These steps are significant for advancing the project and supporting future economic studies and development decisions.
Pacific Ridge Exploration Ltd. (TSXV: PEX, OTCQB: PEXZF) announced it has optioned the Mariposa and Eureka Dome gold projects in Yukon to Labrador Gold Corp. Labrador can acquire a 100% interest in both projects by making cash payments totaling $500,000, issuing 6,670,000 shares, and making exploration expenditures totaling $5,400,000 over four years. An additional $1,000,000 cash payment is due upon the filing of a positive feasibility study. Mariposa comprises 795 claims and Eureka Dome comprises 76 claims, both owned 100% by Pacific Ridge. Significant prior drill results at Mariposa include 2.44 g/t gold over 39 metres.
Rockwell Automation, Inc. (NYSE: ROK) announced that its PlantPAx distributed control system powers a new autonomous AI application developed by Actemium to improve energy efficiency in industrial refrigeration systems for frozen food manufacturing. The Real-Time Coefficient of Performance (RtCOP) solution has helped a large frozen french fry producer increase energy efficiency by 17%, resulting in an estimated $130,000 annual savings per site. Industrial refrigeration can account for up to 70% of a plant's electricity consumption, making this optimization significant. Actemium is working to scale the solution across the producer's fleet of refrigeration plants. The announcement highlights the importance of autonomous optimization in addressing energy costs, equipment reliability, and workforce challenges.
Ceva, Inc. (NASDAQ:CEVA) announced its financial results for the first quarter ended March 31, 2026, reporting total revenues of $27.0 million, an increase of 11% year-over-year. Licensing and related revenues reached $17.8 million, up 18% year-over-year and the highest in three years, while royalty revenues were $9.2 million. The company signed 14 IP licensing agreements and shipped 458 million Ceva-powered devices, including a record 91 million Wi-Fi units. AI represented more than 20% of licensing and related revenues, with key production milestones such as the Renesas R-Car V4H platform entering the 2026 Toyota RAV4.
Gain Therapeutics, Inc. (NASDAQ:GANX) reported financial results for the quarter ended March 31, 2026, highlighting continued progress in the clinical development of its lead candidate GT-02287 for Parkinson’s disease. Research and development expenses increased to $2.8 million, and general and administrative expenses rose to $2.6 million for the quarter. The company reported a net loss of $5,608,732, or $0.13 per share, with cash, cash equivalents, and marketable securities totaling $16.5 million as of March 31, 2026. Key clinical milestones include the completion of enrollment in the Phase 1b nine-month extension for GT-02287 and anticipated FDA clearance of the IND in Q2 2026, with Phase 2 trials expected to begin in Q3 2026.
Baker Hughes (NASDAQ: BKR) announced it has secured a strategic order from San Matias Pipeline S.A. to supply three NovaLT™16 gas turbines with three centrifugal compressors and related services for a major natural gas pipeline project in Argentina. This marks the first use of Baker Hughes’ NovaLT™ gas turbine technology in South America. The equipment will support the transportation of natural gas from the Vaca Muerta formation to the Gulf of San Matias, providing feed gas to Southern Energy’s two floating LNG vessels. The order includes commissioning services, spare parts, special tools, and remote monitoring and diagnostic capabilities. The project reflects growing demand for high-efficiency, lower-emissions turbomachinery in the region.
Baker Hughes (NASDAQ:BKR) and ST LNG, LLC announced an agreement for Baker Hughes to supply gas compression and power generation technology for ST LNG’s proposed 8.4 million tonnes per annum (MTPA) LNG export terminal offshore of Matagorda, Texas. The scope includes two LM6000PF aeroderivative gas turbine driven centrifugal compressor trains and three NovaLT™16 gas turbine generator packages. The first phase of the project is expected to deliver 2.1 MTPA as part of a planned four-phase development, with initial production targeted for mid-2030. Baker Hughes expects to recognize orders associated with this agreement as the project advances. The selection of Baker Hughes represents a significant milestone as the project progresses toward Final Investment Decision.
Baker Hughes (NASDAQ: BKR) announced a substantial 60-month service award from Petrobras to support critical turbomachinery equipment for Brazil’s offshore operations and a major refinery. The agreement, signed in February in Rio de Janeiro, covers maintenance, repairs, and engineering advisory services for up to 64 aeroderivative gas turbines. Work will be delivered from the Baker Hughes Service Center in Petrópolis, Rio de Janeiro, with plans for further expansion. The assets support energy output across approximately 19 FPSO vessels and the Replan refinery in Paulínia, São Paulo. This agreement reinforces Baker Hughes’ commitment to lifecycle services and Brazil’s energy supply chain.
Bengal Energy Ltd. (TSX: BNG) announced the issuance of 20,900,000 options to purchase common shares under its Stock Option Plan. The options were granted on May 8, 2026, to employees, officers, and directors at an exercise price of $0.04/share, which was the closing price on the TSX that day. The options vest over a 3-year period and expire 5 years from issuance. Bengal Energy Ltd. is an international junior oil and gas exploration and production company with assets in Australia. The company aims to grow shareholder value through international exploration, production, and acquisitions.
Union Power Metals Corporation (CSE: UPPR) announced the appointment of Mr. Erez Ichilov as Senior Advisor and Mr. Alexander Ryabchenko as Vice President of Corporate Development. The company granted 3,080,000 performance-vested stock options and 800,000 performance-vested restricted share units to directors, officers, and consultants, all of which vest only upon achieving a market capitalization exceeding $100,000,000 and a 30-day VWAP exceeding $1.00. 2,320,000 of the options and 600,000 RSUs were granted to directors and officers, constituting a related party transaction. The company is focused on advancing high-potential manganese projects in Slovakia and maintains exposure to uranium assets in Botswana.
Eureka Lithium Corp. (CSE: ERKA) (OTCQB: UREKF) announced its intention to change its name to Eureka Metals Corp. to reflect its strategic evolution beyond lithium exploration. The company recently acquired Stairway Mining, giving it a 100% interest in the Tyee Titanium Project in Quebec and an option to acquire a 100% interest in the Cabin Lake Polymetallic Project in British Columbia. The name change is expected to take effect on or about May 14, 2026, with shares continuing to trade under the existing symbols. The CUSIP and ISIN will change to 298601105 and CA2986011054 respectively. No action is required by shareholders regarding the name change.
Lodestar Minerals (ASX:LSR) has defined five new targets with geophysical survey results. The announcement highlights the identification of these targets as a key development. This update is significant for investors as it may indicate potential exploration upside for the company. No financial figures or detailed metrics are provided in the text.
Elevra Lithium (ASX:ELV) has signed a definitive agreement to divest from the company. The announcement details the terms of the divestment and outlines the next steps for the transaction. This development is significant for investors as it may impact the company's future operations and financial position.
Godolphin Resources (ASX: GRL) is set to ramp-up exploration activities. The announcement highlights the company's intention to increase its exploration efforts. This development is significant for investors as it may impact the company's future prospects. No specific financial figures or detailed metrics are provided in the text. The announcement focuses on the company's upcoming exploration plans.
Kropz Plc (AIM: KRPZ) announced the final draw down on its ZAR 250 million (approximately US$ 14.4 million) loan facility, with the last amount of ZAR 40 million now fully drawn. The loan is now fully drawn. Kropz is an emerging African phosphate producer and developer with projects in South Africa and in the Republic of Congo. The announcement was made in accordance with UK MAR regulations and is now considered public information. This development is significant for investors as it marks the completion of a major financing step for the company.
Portmeirion Group PLC has confirmed the appointment of Michael Scheepers as CEO, following the satisfactory completion of the required Nomad due diligence. Michael Scheepers has joined the Board with immediate effect. The announcement also states that Michael Frans Scheepers, aged 47, does not currently hold an interest in the Company's share capital. The company serves diversified international markets, including North America, South Korea, and the United Kingdom. This update is provided in accordance with AIM Rule 17 and Schedule Two (g) of the AIM Rules for Companies.
Neotech Metals Corp. (CSE: NTMC, OTCQB: NTMFF) announced additional assay results from its 2025 10,000 metre drilling and sampling campaign at its 100% wholly-owned Hecla-Kilmer Rare Earth project in Ontario, Canada. The program targeted 8,000 meters of definition, extension, and exploration style targets, with results to be incorporated into the Company's Maiden Resource Estimate expected in 2026. Drill results include intervals such as 372 metres at 0.4% TREO, 65.9 metres at 0.51% TREO, and 76 metres at 0.71% TREO. The company highlighted increasing grades toward the north and mineralization remaining open along strike and at depth. All analytical results have passed internal QA/QC review and compilation.
Panther Metals PLC (LSE: PALM) announced the fifth batch of Vibracore sample assay results for the Winston Tailings Project near Schrieber, Ontario, Canada. The results cover twenty seven Vibracore collar locations and show good grade consistency across the vertical depth-profile and laterally between hole collar locations. Assayed intersections reported for Batch 5 are taken from total tailings thicknesses varying between 1.5m to 15.2m, with a maximum vertical thickness of 16.8m and an average of 8.7m. The results support or exceed previous preliminary assay results and are part of ongoing work to quantify, evaluate, and permit high-grade gold, gallium, silver, zinc, copper, indium, cobalt, and other recoverable minerals in the historic Winston Lake Mine tailings storage facility.
GSK plc announced an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group), through its subsidiary Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ), to accelerate the launch of bepirovirsen in mainland China. Bepirovirsen is a potential first-in-class treatment for chronic hepatitis B, which affects 75 million people in China and is under priority regulatory review in the country. The agreement provides GSK with access to over 5,000 medical centres in China and allows GSK to review SBP Group's early-stage pipeline for potential collaborations. CTTQ will handle importation, distribution, and promotional activities, while GSK retains marketing authorisation and regulatory responsibilities. The initial term of the agreement is 5.5 years, with possible extension.
Savannah Resources Plc (AIM: SAV) announced a notification of major shareholding following the disposal of shares by Al Marjan Limited. As of 8 May 2026, Al Marjan Limited's holding in Savannah Resources decreased to 10.8154% of voting rights, corresponding to 278,405,446 voting rights, down from a previous position of 11.0679% and 284,905,446 voting rights. The Barroso Lithium Project in Portugal, owned by Savannah, is Europe's largest spodumene lithium deposit and was approved for a Portuguese State development Grant of up to €110m in January 2026. The project is classified as a 'Strategic Project' under the European Critical Raw Materials Act and aims to supply lithium for approximately half a million vehicle battery packs per year.
Ionic Rare Earths (ASX: IXR) subsidiary Ionic Technologies has partnered with Less Common Metals, GKN, and Ford UK to demonstrate a circular supply chain for high-performance electric motor rare earth permanent magnets (REPM). The project uses Ionic’s long-loop recycling process to extract and refine rare earth oxides (REOs) with over 99.5% purity, which are then made into finished magnets at GKN’s manufacturing site in Germany. The initiative, supported by the UK government’s CLIMATES program, is seeking £85 million for a UK commercial plant. The project is the first in the Western world to produce recycled, individually separated magnet REOs. This development is significant for reducing reliance on foreign imports and supporting the UK’s clean energy goals.
Elevra Lithium Limited (ASX:ELV; NASDAQ:ELVR) has entered into an agreement to sell its interest in the Ewoyaa Lithium Project in Ghana to Zhejiang Huayou Cobalt Co, Ltd. for approximately US$71 million (before fees and taxes) in cash, with closing expected in Q1FY27. The sale includes all of Elevra's rights and interests, including offtake rights, and is not contingent on Huayou’s separate acquisition of Atlantic Lithium Limited’s interest in the project. Elevra currently owns 32,517,598 shares in Atlantic Lithium Limited, representing approximately 4.1% of the outstanding shares. The transaction is subject to Ghanaian regulatory approvals and is expected to provide Elevra with additional financial flexibility to support its North American growth projects.
ONGold Resources Ltd. (TSXV: ONAU, OTCQB: ONGRF) announced that Gregory Duras is no longer serving as Chief Financial Officer and Corporate Secretary, effective May 7, 2026. Soo-Whan Kim, previously Corporate Controller, has been appointed as Chief Financial Officer and Corporate Secretary, effective May 8, 2026. ONGold Resources Ltd. owns significant exploration assets in Northern Ontario and Northern Manitoba, including the Monument Bay Gold-Tungsten Project, TPK Gold Project, Domain Gold Project, and October Gold Project. The company states that Mr. Kim will continue to lead the Company's financial reporting and accounting functions, ensuring continuity as ONGold advances its strategic initiatives. This leadership transition is important for investors as it addresses continuity in financial management.
SAGA Metals Corp. (TSXV:SAGA, OTCQB:SAGMF) announced the closing of an over-subscribed non-brokered private placement, raising aggregate gross proceeds of C$10,236,486.65 through the issuance of 15,748,441 flow-through common share units at C$0.65 per unit. The company paid C$550,713.54 and issued 847,252 non-transferable finder's warrants as part of the financing. An addendum was signed with Capitaliz Marketing Inc. to increase the marketing campaign budget by an additional $200,000 (CAD). The proceeds will be used for Canadian exploration expenses on the company's mineral resource properties. SAGA Metals continues to advance multiple critical mineral projects in Canada and the United States.
Gran Tierra Energy Inc. announced the results of its annual meeting of stockholders held on May 8, 2026. All five director nominees were elected, and stockholders voted in favor of ratifying KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026. The approval of named executive officer compensation was also passed. The company also released its '2025 Sustainability Report: A Track Record of Creating Long-Term Value, Operating Responsibly, and Being a Trusted Partner.' Gran Tierra is focused on oil and natural gas exploration and production in Canada, Colombia, and Ecuador, and has recently entered into an agreement with SOCAR in Azerbaijan.
Ovintiv Inc. (NYSE: OVV) (TSX: OVV) announced the results of its 2026 Annual Meeting of Shareholders held on May 6, 2026. Each director listed in the Proxy Statement was elected as a director of the Company, with detailed vote counts provided for each nominee. Shareholders also approved, on a non-binding advisory basis, the compensation of the Company's named executive officers, and ratified PricewaterhouseCoopers LLP as independent auditors. The announcement provides exact vote tallies and percentages for each matter.
Argent Trust Company, as Trustee of the Permian Basin Royalty Trust (NYSE: PBT), announced that on May 8, 2026, the 96th District Court of Tarrant County, Texas approved modifications to the Trust's Indenture as requested by SoftVest, L.P., a unitholder. The approved changes eliminate the requirement that certain amendments need approval by 75% of outstanding units and allow amendments by a majority in interest of unitholders constituting a quorum. These changes could impact how future amendments to the Trust's Indenture are made, making it easier for unitholders to approve changes. The announcement also includes cautionary language regarding forward-looking statements.
Boost Run, Inc., a provider of AI cloud infrastructure and high performance compute, announced the completion of its business combination with Willow Lane Acquisition Corp., resulting in gross proceeds of $134.5 million prior to transaction expenses. The company has achieved NVIDIA Exemplar Cloud validation and entered into a $1.44 billion purchase agreement with Dell Technologies to support growing enterprise demand. Boost Run has also expanded its data center capacity in the United States and strengthened its supply and financing relationships. Shares of the company are expected to begin trading on Nasdaq on May 11, 2026, under the ticker 'BRUN.' These developments mark a significant milestone as Boost Run enters the public markets with expanded customer commitments and a growing AI infrastructure footprint.
TOMI Environmental Solutions, Inc. (NASDAQ: TOMZ) reported financial results for Q1 2026, with revenue of $1,654,000, a 5% increase year-over-year, and a 67% sequential increase over Q4 2025. The company announced a non-binding letter of intent to merge with Carbonium Core, Inc., a U.S.-based producer of nuclear-grade graphite, with an implied enterprise valuation of $120 million. Applicator sales surged 139% year-over-year, and total operating expenses declined 15% to $1,458,000. The sales order backlog was $1.7 million as of March 31, 2026, and the integration pipeline grew to approximately $4.3 million across 13 customers. The proposed merger aims to diversify TOMI’s business and expand its presence in advanced graphite and lithium materials.
Inhibrx Biosciences, Inc. (NASDAQ:INBX) announced it will host a live webcast presentation on May 11, 2026, at 5:30 a.m. PT to provide interim results from the Phase 2 HexAgon study evaluating INBRX-106 in combination with pembrolizumab for Head and Neck Squamous Cell Carcinoma. The webcast will be available for 60 days following the event, and the company will update its corporate presentation on its website. Inhibrx Biosciences is a clinical-stage biopharmaceutical company with a pipeline that includes ozekibart and INBRX-106, both utilizing multivalent formats. The company was incorporated in January 2024 as a wholly-owned subsidiary of Inhibrx, Inc. and acquired assets through internal restructuring prior to the sale of Inhibrx, Inc. and the INBRX-101 program to Sanofi S.A. 92% of Inhibrx Biosciences shares were distributed to holders of Inhibrx, Inc. common stock.
Vizsla Copper Corp. (TSXV: VCU) (OTCQB: VCUFF) is advancing copper exploration across its project portfolio, including newly acquired ground in Alaska and an emerging porphyry discovery currently being drilled. The company is targeting copper, zinc, and additional critical minerals within mineral districts known for significant discoveries. This announcement highlights Vizsla Copper Corp.'s ongoing exploration activities and recent acquisitions, which may be of interest to investors seeking exposure to critical minerals exploration.
Inomin Mines Inc. (TSXV: MINE) announced the appointment of Mr. Victor Jaramillo, M.Sc.A., P.Geo., as Vice President of Exploration. Mr. Jaramillo brings over 40 years of international mineral exploration and mine geology experience to the company. In conjunction with his appointment, the company has granted 100,000 stock options to Mr. Jaramillo at an exercise price of $0.105 per share, exercisable until May 8, 2031, with immediate vesting. The appointment is intended to strengthen the company's management team as it advances its Beaver-Lynx polymetallic project and evaluates new acquisition opportunities. The company is engaged in the identification, acquisition, and exploration of mineral properties with strong potential to host significant resources.
Aperam S.A. announced that a notification of share transactions by a Designated Person is available in the Luxembourg Stock Exchange’s electronic database OAM and on Aperam’s website. Aperam is a global player in stainless, electrical and specialty steel and recycling, with customers in over 40 countries. The company has a flat Stainless and Electrical steel capacity of 2.5 million tonnes in Brazil and Europe, and had sales of EUR 6,080 million and shipments of 2.29 million tonnes in 2025. Aperam operates sixteen production facilities in Brazil, Belgium, France, the United States, India, and China. The announcement is made in reference to Article 19(3) of Regulation (EU) No 596/2014 on market abuse.
For investors, this announcement is essentially a non-event: there is no new operational, financial, or strategic information disclosed. The company’s narrative is credible only to the extent that it describes ongoing exploration in Ontario, but there is no evidence of progress, results, or value creation. No notable institutional figures or external investors are referenced, so there is no additional signal of third-party validation or support. To change this assessment, the company would need to disclose concrete milestones—such as completed surveys, assay results, signed property agreements, or financial statements showing cash position and burn rate. In the next reporting period, investors should look for hard data: exploration results, capital raises, or evidence of project advancement. Until then, this announcement should be weighted as routine regulatory compliance, not as a signal to buy, sell, or materially adjust exposure. The most important takeaway is that, absent real numbers or milestones, there is no actionable information here—investors should remain on the sidelines and demand greater transparency before committing capital.
Cytokinetics, Incorporated (Nasdaq: CYTK) announced the closing of an underwritten public offering of 11,338,028 shares of its common stock at a price to the public of $71.00 per share. The offering included the full exercise of the underwriters’ option to purchase up to 1,478,873 additional shares, resulting in gross proceeds of approximately $805 million before deducting underwriting discounts, commissions, and other expenses. All shares were sold by Cytokinetics. The securities were offered pursuant to a shelf registration statement filed on February 27, 2025 with the SEC. This offering provides significant capital to Cytokinetics as it advances its pipeline of cardiovascular medicines.
Restart Life Sciences Corp. (CSE: HEAL) announced a non-brokered private placement financing arrangement to establish a revolving source of dedicated capital for its subsidiary, Holy Crap Foods Inc. The offering consists of up to 833,333 units at a price of CAD $0.12 per unit, for aggregate gross proceeds of up to CAD $100,000 CAD. The financing is designed to support sourcing, manufacturing, and fulfillment activities, enabling uninterrupted production and growth. Each unit includes one common share and one transferable warrant, with each warrant entitling the holder to purchase an additional share at CAD $0.15 for two years. The company is focused on supporting increased sales and production as it enters the busy summer sales season.
Enhanced (NYSE: ENHA), an elite sports competition and consumer products company, has published a shareholder letter from Co-Founder and Chief Executive Officer, Maximilian Martin. The company entered into a business combination agreement with A Paradise Acquisition Corp. (NASDAQ: APAD) in November 2025 to go public via the New York Stock Exchange. Enhanced is preparing to host the inaugural Enhanced Games at Resorts World in Las Vegas on May 24, 2026, featuring a purpose-built 2,500 seat competition complex and a top-flight broadcast production. The company’s business model includes a vertically integrated sports and health platform, with revenue in year one coming almost entirely from sponsorships. Enhanced’s clinical program is structured as an Institutional Review Board (IRB) clinical study, and the company plans to expand its consumer health platform and strategic partnerships as it enters its next phase of growth.
D3 Energy Limited (ASX: D3E; OTCQX: DNRGF) announced a significant increase in its helium resource base after independent certification of a Maiden Contingent and Prospective Resource at its ER386 exploration permit in South Africa's Free State Province. The combined 2C Recoverable Helium Resource across ER315, PR016 and ER386 has grown 65% to 35.6 BCF, and the total Prospective 2U Helium Resource has increased 94% to 52.5 BCF. ER386 covers an area equivalent to 59% of the combined ER315 and PR016 position and is part of D3's 479,409 acre Free State land holding. D3 holds a 100% working interest in ER386. The company also owns helium and hydrogen permits in the Arckaringa Basin, South Australia.
Koppers Holdings Inc. (NYSE: KOP) announced a conditional decision to discontinue distillation and chemical manufacturing operations at its Stickney, Illinois facility, pending union negotiations. This move is expected to impact approximately 85 employees and is driven by challenging market conditions, increased capital requirements, and reduced raw material supply. The company anticipates winding down production by December 31, 2026, and shifting operations to its Nyborg, Denmark facility. The action is anticipated to result in pre-tax charges of $227 million to $262 million through the end of 2029, with annual free cash flow improvement of $15 million to $25 million. Adjusted EBITDA improvement savings are estimated at an annual run rate of approximately $15 million to $20 million in 2027 and beyond.
CG Oncology, Inc. (NASDAQ:CGON) reported financial results for the first quarter ended March 31, 2026, and provided business updates. The company had cash, cash equivalents, and marketable securities of $1.1 billion as of March 31, 2026, sufficient to fund operations through 2029. Key clinical milestones include anticipated BLA completion for HR BCG-unresponsive NMIBC in the fourth quarter of 2026, and topline data from the PIVOT-006 Phase 3 trial expected in the first half of 2026. The company reported a net loss of $60.2 million, or $(0.71) per share, for the first quarter of 2026. CG Oncology strengthened its executive team with the appointment of Jim DeTore as Chief Financial Officer in April 2026.
Soligenix, Inc. (NASDAQ:SNGX) reported its financial results for the quarter ended March 31, 2026, with no revenue and a net loss of $2.8 million, or ($0.28) per share. The company had approximately $6.0 million in cash as of March 31, 2026, providing a cash runway into the 2nd quarter of 2027. The pivotal Phase 3 FLASH2 trial evaluating HyBryte™ in cutaneous T-cell lymphoma (CTCL) was recommended to halt for futility following an interim efficacy analysis. Soligenix is evaluating strategic options, including merger and acquisition opportunities and advancing other pipeline assets such as SGX945 for Behçet's Disease. The company continues to analyze the FLASH2 data and plans to communicate findings and explore follow-up discussions with regulatory agencies.
SAGA Metals Corp. (TSXV:SAGA, OTCQB:SAGMF) announced it has received TSX Venture Exchange approval and closed on the title transfer agreement to acquire a 100% interest in three contiguous mineral licenses comprising 54 mineral claims totaling approximately 1,350 hectares in Labrador. The Wolverine REE Project now comprises nine contiguous mineral licenses totaling approximately 294.5 km². Certified laboratory assays confirm REE enrichment, with grab samples showing up to 21.6% TREO and key drill intercepts including 48.8 m @ 0.77% TREO. The acquisition involves cash payments of $52,700 on closing, $50,000 six months from closing, and 500,000 common shares, plus a 2% net smelter returns royalty. This expansion strengthens SAGA's district-scale opportunity and positions the company for an aggressive 2026 exploration program.
Plains All American Pipeline, L.P. (NASDAQ:PAA) and Plains GP Holdings (NASDAQ:PAGP) reported first-quarter 2026 results, including net income attributable to PAA of $152 million and net cash provided by operating activities of $418 million. The company raised its full-year 2026 Adjusted EBITDA guidance by $130 million to $2.880 billion +/- $75 million, reflecting a strong oil macro environment and NGL contribution into May 2026. Plains paid a quarterly cash distribution of $0.4175 per unit, representing a current distribution yield of approximately 7.5%. The company entered into a definitive agreement to sell substantially all of its NGL business in Canada to Keyera Corp., with the transaction expected to close in May 2026. Maintenance capital increased to $185 million, and full-year 2026 Adjusted Free Cash Flow guidance was increased to approximately $1.850 billion.
Kiora Pharmaceuticals (NASDAQ: KPRX) reported its financial results for the first quarter ended March 31, 2026, and provided updates on its clinical pipeline for retinal diseases. The company ended the quarter with $13.9 million in cash and short-term investments and raised an additional $5.0 million in gross proceeds from a strategic equity investment after the quarter ended. Enrollment in the Phase 2 ABACUS-2 study of KIO-301 remains active, with close to 50% of recruitment completed, and the company is expanding clinical trial sites to meet strong patient demand. Kiora expects its operational runway to extend into late 2028, beyond anticipated clinical data readouts. The publication of ABACUS-1 results in Nature Medicine provides external validation of KIO-301's potential for vision restoration.
Iconic Minerals Ltd. (TSXV: ICM, OTCQB: ICMFF) announced the completion of preparations for a major drilling program at the New Pass gold property in Churchill County, Nevada, under a joint venture with McEwen Mining Inc. (TSX: MUX). American Drilling Corporation has mobilized its equipment, with drilling expected to begin within seven days and to be completed in three months. The program will include 20+ holes ranging from 200 to 600 feet, targeting extensions of the current resource and geophysical anomalies. The New Pass property hosts an inferred resource of 15,515,488 short tons at an average grade of 0.022 oz/ton AuEq, containing 341,750 AuEq ounces. The company aims to expand the known mineralization and enhance project value for shareholders.
Enbridge Inc. (TSX: ENB) (NYSE: ENB) reported first quarter 2026 GAAP earnings attributable to common shareholders of $1.7 billion or $0.77 per common share, down from $2.3 billion or $1.04 per share in 2025. Adjusted earnings were $2.1 billion or $0.98 per share, compared to $2.2 billion or $1.03 per share in 2025. The company reaffirmed its 2026 financial guidance, with adjusted EBITDA targeted between $20.2 billion and $20.8 billion and DCF per share between $5.70 and $6.10. Enbridge sanctioned several major projects, including a US$0.7 billion 300 MW wind facility in Texas and a US$0.4 billion expansion of the Tres Palacios gas storage. The secured capital backlog now stands at approximately $40 billion, with $10 to $11 billion annual investment capacity.
Eureka Lithium Corp. (CSE: ERKA) (OTCQB: UREKF) announced the filing of an independent NI 43-101 technical report for its Cabin Lake Polymetallic Project in British Columbia. The report, effective May 5, 2026, was prepared by Jeremy Hanson, P.Geo., and reviews the project's geological setting, historical exploration, and future work recommendations. Eureka holds an option to acquire a 100% interest in the Cabin Lake Project and already holds a 100% interest in the Tyee Titanium-Vanadium-Scandium Project in Quebec. The technical report supports the company's strategy of advancing mineral exploration assets in stable jurisdictions. The report is available on SEDAR+.
Autoliv, Inc. (NYSE: ALV) announced it will gradually discontinue its manufacturing operations in Türkiye as part of its strategy to align production capacity with future EMEA market requirements. The closure will affect approximately 2,200 employees and is anticipated to be completed in the first half of 2028. Autoliv expects to incur a final pre-tax charge of approximately $142 million for this capacity alignment, with the majority recorded in the second quarter of 2026. The company will move production from Türkiye to other existing facilities in the EMEA region and will retain customer-facing operations in Türkiye. In 2025, Autoliv's sales amounted to $10.8 billion, and its products saved approximately 40,000 lives and reduced around 600,000 injuries.
URU Metals Limited announced the commencement of a ground-based frequency-domain electromagnetic (FDEM) survey at the Zeb Nickel Project. This survey follows the successful completion of a ground-based gravity survey and aims to refine and prioritise drill targets identified from previous airborne surveys. The FDEM survey is designed to provide higher-resolution data to better delineate conductive zones that may represent semi-massive to massive nickel sulphide mineralisation. The company is also preparing Request for Quotation documentation for the selection of a drilling contractor. URU Metals is focused on advancing critical metals projects in South Africa.
Tan Delta Systems plc (AIM:TAND), a UK-based technology leader in real-time oil condition monitoring, announced it has received a Purchase Order worth approximately £395,000 from one of the world leading manufacturers of large commercial & industrial engines. The order is for Tan Delta's real time oil analysis sensor systems, which will be fitted to engines in various industrial and commercial applications. The company highlights this as a successful transition from technology evaluation to rollout, indicating a deepening relationship with the OEM and a significant long-term growth opportunity. This development is important for investors as it demonstrates commercial traction and potential for further expansion.
Arrow Exploration Corp. (AIM: AXL; TSXV: AXL) announced the successful drilling and production of the Mateguafa HZ12 well (M-HZ12) in Colombia, which reached a total measured depth of 13,824 feet and is currently producing at a restricted rate of approximately 564 BOPD gross (282 BOPD net). The company also spud its first Icaco exploration well on May 5, 2026, and plans further development at the Icaco location depending on results. Arrow's total gross corporate production is approximately 5,000 boe/d, with a cash balance of US$24.2 million and no debt as of May 1, 2026. Realized oil prices averaged $87 US/barrel in March and $90 US/barrel in April 2026. Arrow and its partner are in constructive discussions regarding the extension of the Tapir block.
LifeStance Health Group, Inc. (NASDAQ:LFST) announced the pricing of a secondary underwritten public offering of 35,000,000 shares of its common stock at a public offering price of $8.15 per share. The shares are being sold by certain stockholders, and LifeStance will not receive any proceeds from the offering. The company has agreed to repurchase 6,000,000 shares from the underwriter at the same price per share, contingent on the completion of the offering. The offering and repurchase are expected to close on or about May 12, 2026, subject to customary closing conditions. J.P. Morgan is acting as the underwriter for the offering.
For investors, this announcement signals that Consolidated Lithium Metals Inc. is still in the early, pre-acquisition phase of a high-risk, high-reward rare earth project. The company is promoting its intention to earn up to 80% of the Kwyjibo Rare Earth Project, but has not yet secured this interest, and all progress is contingent on completing a technical report by June 2026. The narrative is aspirational and ESG-friendly, but lacks any hard evidence of operational or financial progress—no cash position, no work program milestones, no binding agreements, and no details on how community concerns are being addressed. There are no notable institutional investors or partners disclosed, and the CEO's presence, while necessary, does not provide external validation or guarantee of future funding. To change this assessment, the company would need to disclose concrete progress: signed acquisition agreements, completed technical milestones, detailed financials, or evidence of regulatory and community buy-in. Investors should watch for the actual completion of the technical report, any regulatory approvals, and especially any capital raises or binding project agreements in the next reporting period. At this stage, the information is not actionable for most investors—this is a story to monitor, not a signal to buy. The single most important takeaway is that all value is still hypothetical and years away; until the company delivers hard evidence of progress, the risks far outweigh the potential rewards.
Gran Tierra Energy Inc. reported its financial and operating results for the quarter ended March 31, 2026, achieving a total company average first quarter production of 45,497 BOEPD. The company completed the disposition of its Simonette Montney Block for $49 million, signed an Exploration, Development and Production Sharing Agreement with the State Oil Company of the Republic of Azerbaijan, and entered a strategic partnership with Ecopetrol for operations in the Tisquirama Block. Gran Tierra exited the quarter with $125 million in cash, paid down $133 million of debt, and extended bond maturities to 2031. The company revised its 2026 guidance, forecasting production of 40,000 - 45,000 BOEPD, capital expenditures of $130 - $170 million, and free cash flow of $95 - $115 million.
For investors, this announcement is a classic case of a company selling the future while the present deteriorates. The hard numbers show declining production, falling revenue, shrinking cash flow, and rising debt. While management touts the transformational potential of the Duvernay and power projects, there is no operational or financial evidence yet that these investments are delivering results. The majority of the upside is years away, with most capital spending and expected returns back-end loaded into 2026-2030. No notable institutional investors or external validators are involved, so there is no independent endorsement of the company's strategy or asset quality. To change this assessment, the company would need to provide hard evidence of project commissioning (e.g., power sales, incremental production), binding asset sale agreements, and realised improvements in cash flow and debt metrics. Key metrics to watch in the next reporting period are realised production from new wells, revenue from power projects, and any reduction in net debt or improvement in Adjusted Funds Flow. At this stage, the information is worth monitoring but not acting on: the signal is weak, the risks are high, and the gap between narrative and reality is wide. The single most important takeaway is that Journey's current financial trajectory is negative, and until management delivers tangible, realised results—not just promises—investors should remain cautious.
Centurion Minerals Ltd. (TSXV: CTN) announced that it has executed agreements with two directors to settle $335,000 in outstanding debt by issuing 4,466,666 common shares valued at $0.075 per share. The company chose to satisfy the indebtedness with shares to preserve its cash for operations. The shares for debt transactions are subject to TSX Venture Exchange approval. Centurion Minerals Ltd. is focused on precious mineral asset exploration and development in the Americas. This announcement is significant for investors as it addresses the company's debt management and operational cash preservation.
Amplitude Energy (ASX: AEL) has confirmed it has received production licence VIC/L37. This announcement signifies a regulatory milestone for the company. The granting of the production licence is a key step for Amplitude Energy's operations. Investors should note the explicit confirmation of licence receipt. No financial figures or operational metrics are provided in the text.
American Uranium (ASX: AMU) has kicked off the next phase of drilling. The announcement marks the commencement of a new stage in the company's exploration activities. This development is significant for investors as it indicates ongoing progress in the company's project timeline. No specific financial figures or drilling metrics are provided in the text. The announcement does not mention any locations or detailed operational data.
Cardinal Energy Ltd. (TSX: CJ) announced the results of its annual shareholders' meeting held on May 7, 2026, in Calgary, Alberta. A total of 57,468,030 votes, representing 33.09% of the total votes entitled to vote, were cast in connection with the election of directors. Six directors were nominated and the voting results for each nominee were disclosed, with all other matters put to shareholders duly passed. The company is focused on low decline sustainable oil production in Western Canada. Investors are directed to SEDAR+ for additional voting details.
Lantronix Inc. (NASDAQ:LTRX) announced that its CEO Saleel Awsare and CFO Brent Stringham will participate in two upcoming investor conferences in May 2026. The company describes itself as a global provider of Edge AI and Industrial IoT solutions for unmanned systems, critical infrastructure, and enterprise networks. Lantronix serves high-growth markets such as smart cities, enterprise IT, and commercial and defense unmanned systems. The announcement highlights the company's focus on intelligent computing, secure connectivity, and remote management for mission-critical applications. Investors are informed of opportunities to engage with company leadership at these events.
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) announced that management will participate in several upcoming investor conferences in May 2026, including the Bank of America Securities 2026 Health Care Conference, H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ, and the Stifel 2026 Virtual Ophthalmology Forum. The company applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address diseases with high unmet need, including eye care and infectious disease prevention. XDEMVY (lotilaner ophthalmic solution) 0.25% is FDA approved in the United States for the treatment of Demodex blepharitis. TP-04 and TP-05 are in Phase 2 development for ocular rosacea and Lyme disease prevention, respectively.
Oil Bulletin Daily
Daily signals, E&P company news and macro energy analysis — free, every day.